When I go against the grain, I’m usually right. Don’t buy SpaceX right away.

An AI data stock crushed earnings and ran to new highs. Now it’s resting at the level I want to see break, with three squeezes stacking up and a heavy short float underneath. If that level breaks, the move comes fast. This is the playbook I’m hunting all week. I want earnings winners with high … Continued

The sectors being punished hardest by the Iran conflict will rebound fastest when it ends. Here’s what history says and where Karim is already positioning.

The most powerful AI chips in the world share one manufacturer. Nvidia, Apple, and AMD all design their chips in-house but ship the blueprints to the same place to be manufactured. Taiwan Semiconductor Manufacturing Company (TSM), is where every major AI chip moves from blueprint to finished product. No other company builds at this scale … Continued

While the S&P 500 may be recording all-time highs, this critical chart tells the real story… and it’s not as pretty.

Two years ago, Marvell (MRVL) had no custom silicon business. Today it’s a $1.5 billion revenue line and growing. Amazon’s Trainium chip and Microsoft’s Maia accelerator both run on Marvell silicon. Google is a customer too, and Marvell works directly with Nvidia on bandwidth and connectivity for AI data centers. Its management expects the custom … Continued

The bond market had its worst week in a year, the market is showing exhaustion at a near-term top, and the Dark Ticker gave one member over 120% gains this morning.

There’s a set of instructions buried inside virtually every smartphone, AI server, and cloud processor on earth. They belong to one British company. ARM Holdings (ARM) doesn’t manufacture chips. It designs the instruction set architecture, the blueprint that tells a chip how to execute code, and licenses that blueprint to every major chipmaker in the … Continued

AOL’s founder picked a spot one development over from where I just stayed. The reasons matter.

A small-cap just doubled on its earnings beat. The next day it ran another 25%. Now it’s taking a breather right in my favorite chart pattern, and 70% of the float is sold short underneath it. If buyers step back in here, the move will be fast. That’s the kind of setup I’m hunting all … Continued

The Cerebras IPO looked exactly like one from the dot-com era. Bryan was on the CBOE floor when it happened the first time.

When you look at Kenvue (KVUE), you may see a boring consumer health company. I’m not sure that’s a fair assessment, considering they’re the world’s largest pure-play consumer health company by revenue, generating $15.5 billion in net sales in 2024. Their products may be boring: Tylenol, Listerine, Band-Aids… but you can’t say they aren’t under … Continued